---  
layout: startup_page  
title: "Clasp Therapeutics"  
id: "clasptx.com"  
permalink: "/clasptherapeuticsclasptx.com03202024/"  
website: "https://www.clasptx.com/home#about-us"  
funding_round: "Series A"  
funding_amount: "$150M"  
investors: "Catalio Capital Management, Third Rock Ventures, Novo Holdings, Vivo Capital, Cure Ventures, Blackbird BioVentures, Pictet Alternative Advisors, American Cancer Societyâ€™s Bright Edge, Alexandria Venture Investments"  
about: "Clasp Therapeutics is a biotechnology company developing modular T cell engagers (TCEs) for precise immuno-oncology treatments. Their platform targets oncogenic driver mutations, creating off-the-shelf medicines to address hard-to-treat cancers with high specificity. This approach aims to eradicate tumors while minimizing toxicity."  
markets: "Biotechnology, Therapeutics"  
hq: "Rockville, Maryland, United States"  
founded_year: "2020"  
linkedin: "https://www.linkedin.com/company/clasp-therapeutics"  
twitter: ""  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/clasp-therapeutics"  
pitchbook: "https://pitchbook.com/profiles/company/591278-23"  

date_display: "20-Mar-2024"  
date: "2024-03-20"

# SEO Optimization  
meta_title: "Clasp Therapeutics - Series A Funding ($150M)"  
meta_description: "Clasp Therapeutics, Clasp Therapeutics is a biotechnology company developing modular T cell engagers (TCEs) for precise immuno-oncology treatments. Their platform targets..."  
meta_keywords: "Clasp Therapeutics, Biotechnology, Therapeutics, Series A funding"  
canonical_url: "https://startup.projectstartups.com/clasptherapeuticsclasptx.com03202024/"  
---